Delcath Systems, Inc

Advancing interventional oncology with a focus on liver-directed therapies for patients with liver-dominant cancers. | NASDAQ: DCTH

[Delcath Systems, Inc @DelcathSystems]

Finding experienced uveal melanoma care? Ask about a specialist’s experience with your diagnosis, referrals and coordination with your other doctors.
https://t.co/oKsy1JHTol
Sponsored by Delcath. #UvealMelanoma

[Delcath Systems, Inc @DelcathSystems]

Education and connection at #EyeBelieve: read our recap of A Cure In Sight’s 2026 seminar for the ocular melanoma community. Delcath was proud to support the event.
https://t.co/zcr13wNajg
#OcularMelanoma

[Delcath Systems, Inc @DelcathSystems]

New treatment in Nebraska targets rare melanoma that spreads from eye to liver https://t.co/VwqulC063h via @owhnews

[Delcath Systems, Inc @DelcathSystems]

For National Health Education Week, we recognize the people who make health information easier to understand. Explore uveal melanoma education: https://t.co/nXnlLUzwLb
Sponsored by Delcath. #HealthEducation

[Delcath Systems, Inc @DelcathSystems]

During #PharmacyWeek, October 18–24, we recognize pharmacists and pharmacy technicians for their contributions to medication safety and patient care. Thank you for all you do.

[Delcath Systems, Inc @DelcathSystems]

A few questions for your next uveal melanoma appointment: What is my follow-up plan? Who can I contact between visits? Where can I learn more?
Explore https://t.co/nXnlLUzwLb. Sponsored by Delcath.
#UvealMelanoma

[Delcath Systems, Inc @DelcathSystems]

Attending #ESMO2026 in Madrid? Visit Delcath at Booth 1092 to talk liver-directed therapy and our ongoing clinical research in liver-dominant metastatic disease. October 23-27, 2026

[Delcath Systems, Inc @DelcathSystems]

Why is the liver part of the uveal melanoma conversation? Learn about liver monitoring and follow-up care: https://t.co/zun02YNmPb

[Delcath Systems, Inc @DelcathSystems]

On #MBCAwarenessDay, we stand with people living with metastatic breast cancer. Learn about the Deluma study for mBC that has predominantly spread to the liver: https://t.co/fLDUQlGkSy

[Delcath Systems, Inc @DelcathSystems]

Uveal melanoma isn't the same as skin melanoma. Learn how they differ: https://t.co/xzfW9fiLKH

[Delcath Systems, Inc @DelcathSystems]

Facing a uveal melanoma diagnosis? https://t.co/nXnlLUzwLb is a new resource for patients and caregivers covering the disease, liver monitoring and finding experienced care. Sponsored by Delcath

[Delcath Systems, Inc @DelcathSystems]

Complex procedures don't get adopted on data alone. Physicians need to see them first.

That's why we brought an immersive VR experience of percutaneous hepatic perfusion to #CIRSE2026. Here's why we're investing in it: https://t.co/PGuEQawPZc

[Delcath Systems, Inc @DelcathSystems]

Delcath Systems ($DCTH) has been added to the S&P Healthcare Equipment Select Industry Index.

Company news and investor updates: https://t.co/46povJs3Zd (https://t.co/FaqcPTdFPu)

#Delcath

[Delcath Systems, Inc @DelcathSystems]

It’s #LiverCancerAwarenessMonth. When uveal melanoma spreads, the liver is the most common site where metastatic disease is identified.

Why the liver matters during follow-up: https://t.co/Vc75i6NNZV

#UvealMelanoma

[Delcath Systems, Inc @DelcathSystems]

On #RareCancerDay, we recognize everyone affected by rare cancers, including uveal melanoma.

Learn more in What Is Uveal Melanoma? A Patient’s Guide to This Rare Cancer: https://t.co/zhFW7YpgDY #UvealMelanoma #RareCancer

[Delcath Systems, Inc @DelcathSystems]

In recognition of World Cancer Research Day, Delcath celebrates those advancing cancer research and scientific discovery.

Learn more about our Research and Educational Support portal: https://t.co/Gej4cVa1bX

#WorldCancerResearchDay #CancerResearch #Oncology

[Delcath Systems, Inc @DelcathSystems]

A Cure In Sight’s Eye Believe Survivorship Seminar brings the ocular melanoma community together for education, connection and support on October 3.

Learn more and register: https://t.co/TQKKjdiG3P

#EyeBelieve #UvealMelanoma

[Delcath Systems, Inc @DelcathSystems]

Uveal melanoma is a rare cancer that begins in the uvea, the middle layer of the eye—and is biologically different from melanoma of the skin.

Learn about possible symptoms, diagnosis and ongoing monitoring: https://t.co/zhFW7YoIOq

#UvealMelanoma

[Delcath Systems, Inc @DelcathSystems]

This #APPWeek, we recognize the Advanced Practice Providers whose expertise and collaboration support patients and oncology care teams every day.

To APPs across cancer care, thank you for all that you do.

#CelebrateAPPs #AdvancedPracticeProviders #Oncology

[Delcath Systems, Inc @DelcathSystems]

Our three Queensbury, NY, offices brought a little island spirit to the workplace for Luau Day! Everyone enjoyed a themed lunch and plenty of island-inspired fun.

Pictured L-R: Josh Shpur, Shannon Passino, Christine Cuthbert, Chrystyne McCarthy, Shannon Gaddin, Aishwarya Wagh, Danya Navarrete & Kaileigh Parish.

#Delcath #CompanyCulture